Six immune hub genes (KLRC2, KLRC3 SH2D1B, GZMB, KIR2DL3, and KIR3DL2) identified by our bioinformatics analyses may provide new diagnostic and therapeutic targets for VKH disease. This evidence concerns the gene KIR3DL2 and Vogt-Koyanagi-Harada disease.